These two cancer marker genes, MKI167 and BIRC5, have been reported to be highly expressed in cervical cancer in many studies, where they are associated with the cell cycle pathway and cell apoptosis inhibition, respectively, and are both involved in breast cancer pathogenesis (51–53). Here, BIRC5 is linked to breast carcinoma.